ranitidine: be given in anaphylaxis

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents medication
Weight: 0.44
, antihistamine
Weight: 0.42
, symptom
Weight: 0.29
Siblings acetaminophen
Weight: 0.32
, ibuprofen
Weight: 0.32
, phenobarbital
Weight: 0.32
, corticosteroid
Weight: 0.32
, benzodiazepine
Weight: 0.32

Related properties

Property Similarity
be given in anaphylaxis 1.00
be used for anaphylaxis 0.98
be given for asthma 0.80
work for allergies 0.80
help allergies 0.79
be contraindicated in asthma 0.77
be used for asthma 0.76
cause hyperglycemia 0.76
be used in asthma 0.76
be useful in asthma 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.49
Rule weight: 0.66
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.89
Plausible(antihistamine, work for allergies)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)
0.46
Rule weight: 0.66
Evidence weight: 0.91
Similarity weight: 0.77
Evidence: 0.86
Plausible(antihistamine, be contraindicated in asthma)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)
0.45
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.76
Evidence: 0.81
Plausible(antihistamine, be used for asthma)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)
0.40
Rule weight: 0.66
Evidence weight: 0.77
Similarity weight: 0.79
Evidence: 0.64
Plausible(antihistamine, help allergies)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)
0.39
Rule weight: 0.66
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.64
Plausible(antihistamine, be used in asthma)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.64
¬ Plausible(antihistamine, help allergies)
0.06
Rule weight: 0.09
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.64
¬ Plausible(antihistamine, be used in asthma)
0.05
Rule weight: 0.09
Evidence weight: 0.72
Similarity weight: 0.80
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.89
¬ Plausible(antihistamine, work for allergies)
0.05
Rule weight: 0.09
Evidence weight: 0.75
Similarity weight: 0.76
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.81
¬ Plausible(antihistamine, be used for asthma)
0.05
Rule weight: 0.09
Evidence weight: 0.73
Similarity weight: 0.77
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.86
¬ Plausible(antihistamine, be contraindicated in asthma)

Remarkability exclusitivity betweem a parent and a child

0.21
Rule weight: 0.58
Evidence weight: 0.46
Similarity weight: 0.80
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.71
¬ Remarkable(antihistamine, work for allergies)
0.19
Rule weight: 0.58
Evidence weight: 0.44
Similarity weight: 0.77
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.74
¬ Remarkable(antihistamine, be contraindicated in asthma)
0.19
Rule weight: 0.58
Evidence weight: 0.43
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.75
¬ Remarkable(antihistamine, be used for asthma)
0.16
Rule weight: 0.58
Evidence weight: 0.35
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.85
¬ Remarkable(antihistamine, help allergies)
0.15
Rule weight: 0.58
Evidence weight: 0.35
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.85
¬ Remarkable(antihistamine, be used in asthma)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.77
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.59
¬ Remarkable(ibuprofen, be contraindicated in asthma)
0.05
Rule weight: 0.13
Evidence weight: 0.49
Similarity weight: 0.80
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.68
¬ Remarkable(corticosteroid, be given for asthma)
0.04
Rule weight: 0.13
Evidence weight: 0.44
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.74
¬ Remarkable(corticosteroid, cause hyperglycemia)
0.04
Rule weight: 0.13
Evidence weight: 0.41
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.78
¬ Remarkable(corticosteroid, be used for asthma)
0.04
Rule weight: 0.13
Evidence weight: 0.38
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.82
¬ Remarkable(corticosteroid, be useful in asthma)

Remarkability from parent implausibility

0.33
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.89
Plausible(antihistamine, work for allergies)
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.69
¬ Plausible(ranitidine, be given in anaphylaxis)
0.31
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.86
Plausible(antihistamine, be contraindicated in asthma)
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.69
¬ Plausible(ranitidine, be given in anaphylaxis)
0.31
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.64
Plausible(antihistamine, help allergies)
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.69
¬ Plausible(ranitidine, be given in anaphylaxis)
0.31
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.81
Plausible(antihistamine, be used for asthma)
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.69
¬ Plausible(ranitidine, be given in anaphylaxis)
0.30
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.64
Plausible(antihistamine, be used in asthma)
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.69
¬ Plausible(ranitidine, be given in anaphylaxis)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.80
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.68
Remarkable(corticosteroid, be given for asthma)
Evidence: 0.63
¬ Plausible(corticosteroid, be given for asthma)
0.44
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.82
Remarkable(corticosteroid, be useful in asthma)
Evidence: 0.63
¬ Plausible(corticosteroid, be useful in asthma)
0.44
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.78
Remarkable(corticosteroid, be used for asthma)
Evidence: 0.63
¬ Plausible(corticosteroid, be used for asthma)
0.43
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.76
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.74
Remarkable(corticosteroid, cause hyperglycemia)
Evidence: 0.82
¬ Plausible(corticosteroid, cause hyperglycemia)
0.42
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.77
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.59
Remarkable(ibuprofen, be contraindicated in asthma)
Evidence: 0.79
¬ Plausible(ibuprofen, be contraindicated in asthma)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.82
¬ Salient(ranitidine, be given in anaphylaxis)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.98
Evidence: 0.82
Salient(ranitidine, be given in anaphylaxis)
Evidence: 0.87
¬ Salient(ranitidine, be used for anaphylaxis)
0.70
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.98
Evidence: 0.76
Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.68
¬ Remarkable(ranitidine, be used for anaphylaxis)
0.64
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.98
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.78
¬ Plausible(ranitidine, be used for anaphylaxis)
0.61
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.98
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.78
¬ Typical(ranitidine, be used for anaphylaxis)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.82
Salient(ranitidine, be given in anaphylaxis)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.69
Plausible(ranitidine, be given in anaphylaxis)
Evidence: 0.65
¬ Typical(ranitidine, be given in anaphylaxis)

Typicality and Rermarkability incompatibility between a parent and a child

0.24
Rule weight: 0.51
Evidence weight: 0.59
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.55
¬ Typical(antihistamine, help allergies)
0.23
Rule weight: 0.51
Evidence weight: 0.59
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.54
¬ Typical(antihistamine, be used in asthma)
0.15
Rule weight: 0.51
Evidence weight: 0.39
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.81
¬ Typical(antihistamine, be used for asthma)
0.13
Rule weight: 0.51
Evidence weight: 0.34
Similarity weight: 0.77
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.88
¬ Typical(antihistamine, be contraindicated in asthma)
0.13
Rule weight: 0.51
Evidence weight: 0.31
Similarity weight: 0.80
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.91
¬ Typical(antihistamine, work for allergies)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.58
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.56
¬ Typical(corticosteroid, be useful in asthma)
0.06
Rule weight: 0.14
Evidence weight: 0.56
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.58
¬ Typical(corticosteroid, be used for asthma)
0.06
Rule weight: 0.14
Evidence weight: 0.51
Similarity weight: 0.80
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.65
¬ Typical(corticosteroid, be given for asthma)
0.04
Rule weight: 0.14
Evidence weight: 0.37
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.82
¬ Typical(corticosteroid, cause hyperglycemia)
0.04
Rule weight: 0.14
Evidence weight: 0.35
Similarity weight: 0.77
Evidence: 0.76
¬ Remarkable(ranitidine, be given in anaphylaxis)
Evidence: 0.85
¬ Typical(ibuprofen, be contraindicated in asthma)

Typicality inheritance from parent to child

0.31
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.55
¬ Typical(antihistamine, help allergies)
0.30
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 0.76
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.54
¬ Typical(antihistamine, be used in asthma)
0.27
Rule weight: 0.48
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.81
¬ Typical(antihistamine, be used for asthma)
0.26
Rule weight: 0.48
Evidence weight: 0.68
Similarity weight: 0.80
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.91
¬ Typical(antihistamine, work for allergies)
0.26
Rule weight: 0.48
Evidence weight: 0.69
Similarity weight: 0.77
Evidence: 0.65
Typical(ranitidine, be given in anaphylaxis)
Evidence: 0.88
¬ Typical(antihistamine, be contraindicated in asthma)